Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002794 · ClinicalTrials.gov registry record · Phase 2
Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
A Phase 2 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00002794 is a Phase 2 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 25 participants.
The verdict
NCT00002794, a Phase 2 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of carboplatin plus vincristine in treating children with retinoblastoma.
Interventions
- DRUG carboplatin
- DRUG vincristine sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 1996-02 |
| Est. Completion | 2001-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002794
The ClinicalTrials.gov registry entry for NCT00002794 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which carboplatin is the first listed.
NCT00002794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002794 about?
NCT00002794 is a clinical study titled "Carboplatin Plus Vincristine in Treating Children With Retinoblastoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of carboplatin plus vincristine in treating children with retinoblastoma...
What is the current status of trial NCT00002794?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 1996-02. Estimated completion is 2001-06.
What interventions are being tested in trial NCT00002794?
The interventions under investigation include: carboplatin (DRUG), vincristine sulfate (DRUG).
Who is sponsoring clinical trial NCT00002794?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.